Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...

Shares rose 6.7% to $71.95, putting the stock on pace for its highest close since last September, according to Dow Jones ...

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.17%, ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical ...

FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...

Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom today and set a price target of $86.00. According to TipRanks, Hambright is a 4-star analyst with an average return of 8.1% and a ...

The ‍guidance, along with comments from ​FDA Commissioner Marty Makary, adds to existing policy that classifies low-risk ...

Contract Inflows and Solid Backlog Aid Leidos Holdings (LDOS) According to the Zacks analyst, Leidos Holdings is benefiting ...

Ulster back row Juarno Augustus is ruled out for "a number of weeks" with an ankle ligament injury sustained in the win over ...